Drug
Srp 9005
Srp 9005: highest development phase Phase 3, developed by Sarepta Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sarepta Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| SRP-9005 NCT06952686 | Phase 3 | Muscular Dystrophies, Limb-Girdle |
Latest
No recent events.
Follow Srp 9005 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.